JOEI HARRIS: Open Payments
NPI 1992480438 · WOODBURY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 99 payments from 22 companies in 2025. Trend: 2023 $418 · 2024 $1,449 · 2025 $2,028
Food & beverage: $2,028
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $309 |
| Axsome Therapeutics, Inc. | 10 | $245 |
| Novo Nordisk Inc | 13 | $209 |
| Corcept Therapeutics | 7 | $194 |
| ABBVIE INC. | 11 | $164 |
| Mannkind Corporation | 5 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Alkermes, Inc. | 3 | $71 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
Products named: REXULTI, Auvelity, Korlym, AFREZZA, Ozempic, CAPLYTA, VRAYLAR, Kerendia.
Industry payments across TN — which companies pay providers there.
